Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
CCR2-targeted antibody-drug conjugate
DRUG CLASS:
CCR2-targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
TAK-500 (1)
TAK-500 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCR2 overexpression
Non Small Cell Lung Cancer
CCR2 overexpression
Non Small Cell Lung Cancer
TAK-500
Sensitive: D – Preclinical
TAK-500
Sensitive
:
D
TAK-500
Sensitive: D – Preclinical
TAK-500
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.